Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

JR, Wright; YC, Ung; JA, Julian; KI, Pritchard; TJ, Whelan; C, Smith; B, Szechtman; W, Roa; L, Mulroy; L, Rudinskas; B, Gagnon; GS, Okawara; MN, Levine

doi:10.1200/jco.2006.07.1514

Public

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

Shared by NobleBlocks on Feb 20, 2007 • 12:00 AM UTC

Authors:

Wright JR

Ung YC

Julian JA

Abstract

Purpose Previous trials have suggested a quality-of-life (QOL) improvement for anemic cancer patients treated with erythropoietin, but few used QOL as the primary outcome. We designed a trial to investigate the effects of epoetin alfa therapy on the QOL of anemic patients with advanced non-small-cel...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!